Protein phosphatase 2A: a target for anticancer therapy.
about
Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathwayThe broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillanceThe emerging role of FTY720 (Fingolimod) in cancer treatmentProtein Phosphatase 2A as a Therapeutic Target in Acute Myeloid LeukemiaFas Versatile Signaling and Beyond: Pivotal Role of Tyrosine Phosphorylation in Context-Dependent Signaling and DiseasesThe Basic Biology of PP2A in Hematologic Cells and MalignanciesPP2A: The Wolf in Sheep's Clothing?Immediate-early response 5 (IER5) interacts with protein phosphatase 2A and regulates the phosphorylation of ribosomal protein S6 kinase and heat shock factor 1Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET proteinRegulation of PI3K effector signalling in cancer by the phosphoinositide phosphatasesActivation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.Striatins contain a noncanonical coiled coil that binds protein phosphatase 2A A subunit to form a 2:2 heterotetrameric core of striatin-interacting phosphatase and kinase (STRIPAK) complex.The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion.Cyanobacterial Toxins of the Laurentian Great Lakes, Their Toxicological Effects, and Numerical Limits in Drinking WaterThe role of SET/I2PP2A in canine mammary tumors.From the Biology of PP2A to the PADs for Therapy of Hematologic MalignanciesPhosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer.The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsStructure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cellsPP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effectsBasal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolinDominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin.A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancerBRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.Cell Density-Dependent Increase in Tyrosine-Monophosphorylated ERK2 in MDCK Cells Expressing Active Ras or Raf.Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells.The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2AProtein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.Cardiomyocyte specific deletion of PP2A causes cardiac hypertrophy.Conditional Knockout in Mice Reveals the Critical Roles of Ppp2ca in Epidermis Development
P2860
Q24338396-6AE77C80-38DF-4D47-B993-15026F398249Q26739246-BD3027C0-6551-4A46-9A69-9B420B0485ADQ26748927-EE73E408-84D5-4D30-8FA5-F033A713B0F6Q26752430-8709D806-6A28-452F-8129-550CDB99BC1EQ28073778-3D92A4D2-303D-4735-B04B-C483F8F9D7F9Q28088697-9F4BBD2E-3174-4DBE-B2F4-163BD96D8756Q28088747-E1D922EB-869A-4515-8DA6-92A898E0C0CEQ28118123-51FAD729-2B70-452B-B79B-5353FA3BED8DQ28538642-DE00474C-D203-41BC-98D0-0CF94C4569D1Q29248612-BFBC458E-2123-4BDB-8879-B48A5C074C23Q30252408-FDF8DB72-A54D-4EED-AEB3-E8C0A17B3622Q30359226-AEE49F23-B5C8-4C60-AA99-2AF27FB30BF2Q33613072-9AE9C39F-CC04-4731-9E5B-46B18CD984EDQ33833344-31C3FC7D-EBA0-4E79-B20D-2CC202EF7F90Q33842870-8413D88F-35EF-4DDD-99EF-9575457A910BQ34043449-210EB624-3647-4734-A801-3FB72BA0EA6DQ34051988-800724CD-981B-4CCB-B6DD-71EEB61A3025Q34194198-67406A1C-EF9C-4AA8-BB4C-FD5240425987Q34542598-A96A51F5-3850-4DE4-9E2C-890F5015E4BDQ34571406-C16995A9-C9C5-4FA7-A0B5-9AF0CDA43737Q34978247-E59D4EAC-1464-4C8B-A83E-2AC6BA022595Q35000235-EFF19239-5506-4B35-8423-A58FE62BC876Q35024079-7ED82092-AAF1-46D4-89E9-A87C5CC36883Q35552005-1C4D69A3-28D3-498C-BF54-2E936FA7D5F0Q35617207-0A7B8A2E-88E6-46DF-8C6B-148A4424E629Q35757055-EF978A5C-0E5C-405F-AFF4-0B7A4D9D8ED8Q35953902-C78DF873-5FCC-493D-8529-B7720C2D356EQ36020877-DC1C7522-8016-4158-B66A-874736936CDFQ36022236-DEC44D87-E3B0-4683-9B1B-AEAF43A33B96Q36189172-C23A4AB9-8D5B-4EB6-925F-6D09C9DCCDDDQ36216530-06AA68EC-68D4-48EB-8B46-CC1AFEF60BF3Q36218706-17C4CD8D-696E-4682-886A-6D015EE8E24EQ36283299-871A37D7-DB0B-477B-84E0-C2B11B80702EQ36323864-301A47B6-6706-4B9D-B203-355DFC96729EQ36454002-BDB52E21-B490-43C3-8B88-B8D537999353Q36579794-B2CA696B-8325-4391-99B3-626F10DD6AEFQ36729492-CD22A666-C001-4F3D-81A8-4618C77D7704Q36796805-1E2ADE57-D8FF-4004-94B2-2B0C0B9C4864Q36879581-149856A9-FBB1-49FB-92DA-0B6D7DBBDF46Q36939325-70C8932A-0AEB-41A2-9DF1-128FA21A5E2C
P2860
Protein phosphatase 2A: a target for anticancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protein phosphatase 2A: a target for anticancer therapy.
@en
type
label
Protein phosphatase 2A: a target for anticancer therapy.
@en
prefLabel
Protein phosphatase 2A: a target for anticancer therapy.
@en
P2860
P1433
P1476
Protein phosphatase 2A: a target for anticancer therapy.
@en
P2093
Danilo Perrotti
Paolo Neviani
P2860
P304
P356
10.1016/S1470-2045(12)70558-2
P577
2013-05-01T00:00:00Z